| Literature DB >> 32097629 |
Andrew Kodani1, Connor Kenny2, Abbe Lai3, Dilenny M Gonzalez2, Edward Stronge2, Gabrielle M Sejourne2, Laura Isacco2, Jennifer N Partlow2, Anne O'Donnell4, Kirsty McWalter5, Alicia B Byrne6, A James Barkovich7, Edward Yang8, R Sean Hill2, Pawel Gawlinski9, Wojciech Wiszniewski10, Julie S Cohen11, S Ali Fatemi12, Kristin W Baranano11, Mustafa Sahin13, David G Vossler14, Christopher J Yuskaitis15, Christopher A Walsh16.
Abstract
Genes mutated in human neuronal migration disorders encode tubulin proteins and a variety of tubulin-binding and -regulating proteins, but it is very poorly understood how these proteins function together to coordinate migration. Additionally, the way in which regional differences in neocortical migration are controlled is completely unknown. Here we describe a new syndrome with remarkably region-specific effects on neuronal migration in the posterior cortex, reflecting de novo variants in CEP85L. We show that CEP85L is required cell autonomously in vivo and in vitro for migration, that it localizes to the maternal centriole, and that it forms a complex with many other proteins required for migration, including CDK5, LIS1, NDE1, KIF2A, and DYNC1H1. Loss of CEP85L disrupts CDK5 localization and activation, leading to centrosome disorganization and disrupted microtubule cytoskeleton organization. Together, our findings suggest that CEP85L highlights a complex that controls CDK5 activity to promote neuronal migration.Entities:
Keywords: CDK5; CEP85L; Centrosome; De novo; Lissencephaly; Pachygyria; genetics; neurodevelopment
Mesh:
Substances:
Year: 2020 PMID: 32097629 PMCID: PMC7255387 DOI: 10.1016/j.neuron.2020.01.030
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 18.688